Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program
NCT ID: NCT00233129
Last Updated: 2013-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2005-10-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Executive Functioning After Traumatic Brain Injury (TBI): A Trial of the "Short Term Executive Plus" Program
NCT00627237
Participation and Executive Functions in Adults Following Traumatic Brain Injury In Sub-Acute Inpatient Rehabilitation
NCT04292925
To Compare the Effect of Receiving the Technology-based Training Along With the Conventional Therapy to the Conventional Therapy Alone on Executive Functions Among People With Traumatic Brain Injury With Mild to Moderate Cognitive Deficit
NCT06080269
Improving New Learning and Memory in Traumatic Brain Injury
NCT01207375
Online Emotion Regulation Group Intervention
NCT03479606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Treatment
cognitive rehabilitation day treatment program
cognitive rehabilitation day treatment program
six months
Top-Down
cognitive rehabilitation day treatment program that incorporates systematic "top down" treatment of executive function deficits (problem solving and emotional regulation training), systematic treatment of attention deficits, and modular, contextual and embedded approaches to treatment.
Top Down
Six months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Top Down
Six months
cognitive rehabilitation day treatment program
six months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a TBI as a result of a blow to the head followed by a loss of consciousness or period of being dazed and confused or a period of post traumatic amnesia or clinical signs of altered neurological function; this information must be medically documented (e.g., emergency medical record, hospital record, neuroradiological report, or neurological exam or record of physician's visit within 24 hours of injury).
* At least three months post-injury
* English-speaking (treatment sessions will be conducted in English)
* Reporting executive dysfunction (by self or family)
* Willing and able to participate in and travel to the program daily for six months
* Oriented to time, place and person
* Having a full-scale intelligence quotient (IQ) of at least 75
* Having a score on the Galveston Orientation and Amnesia Test of 75 or more
* Having communication skills adequate to participate in groups
* Having at least a sixth-grade reading level (for testing and use of written materials)
* Willing to complete questionnaires and interviews about mood, thinking skills, participation and the like
* Agree to participate, i.e., completion of informed consent and Health Insurance Portability and Accountability Act (HIPAA) documents
Exclusion Criteria
* Active psychosis
* Active suicidality
* Disruptive or violent behavior to self or others
* Current cognitive rehabilitation (this does not include psychotherapy)
* No impairment on the Frontal Systems Behavior Scale (FRSBE) or Wisconsin Card Sorting Test (WCST)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. Department of Education
FED
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wayne A Gordon, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#H133B040033
Identifier Type: -
Identifier Source: secondary_id
GCO# 04-0782
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.